Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
270
Top-10 weight
39.44%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
39
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1009.2
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 1,200,478 | $1.10B | 10.14% |
| 2 | THERMO FISHER SCIENTIFIC INC | — | 900,979 | $442.86M | 4.07% |
| 3 | INTUITIVE SURGICAL INC | — | 863,221 | $397.94M | 3.65% |
| 4 | STRYKER CORP | — | 1,147,522 | $377.06M | 3.46% |
| 5 | MERCK & CO | — | 3,116,392 | $374.87M | 3.44% |
| 6 | ASTRAZENECA PLC | — | 1,751,235 | $345.38M | 3.17% |
| 7 | UNITEDHEALTH GRP | — | 1,242,865 | $336.31M | 3.09% |
| 8 | ARGENX SE SPONSORED ADR | — | 435,310 | $317.89M | 2.92% |
| 9 | ABBVIE INC | — | 1,423,341 | $309.56M | 2.84% |
| 10 | REGENERON PHARMACEUTICALS INC | — | 373,226 | $288.37M | 2.65% |
| 11 | GILEAD SCIENCES INC | — | 2,034,836 | $283.60M | 2.60% |
| 12 | JOHNSON&JOHNSON | — | 1,088,355 | $266.04M | 2.44% |
| 13 | VERTEX PHARMACEUTICALS INC | — | 591,295 | $264.04M | 2.42% |
| 14 | DANAHER CORP | — | 1,175,471 | $222.87M | 2.05% |
| 15 | ALNYLAM PHARMACEUTICALS INC | — | 531,894 | $175.99M | 1.62% |
| 16 | Ascendis Pharma A/S | — | 676,173 | $154.66M | 1.42% |
| 17 | REVOLUTION MEDICINES INC | — | 1,519,722 | $147.79M | 1.36% |
| 18 | UNITED THERAPEUTICS CORP DEL | — | 246,943 | $146.43M | 1.34% |
| 19 | BEONE MEDICINE-H | — | 5,757,796 | $129.16M | 1.19% |
| 20 | ROIVANT SCIENCES LTD | — | 4,447,673 | $123.20M | 1.13% |
| 21 | PROTAGONIST THERAPEUTICS INC | — | 1,142,059 | $120.37M | 1.11% |
| 22 | INSMED INC | — | 702,695 | $114.90M | 1.05% |
| 23 | SUMMIT THERAPEUTICS INC | — | 5,948,323 | $112.78M | 1.04% |
| 24 | NATERA INC | — | 561,746 | $112.34M | 1.03% |
| 25 | TENET HEALTHCARE CORP | — | 580,102 | $109.47M | 1.00% |
| 26 | BRIGHTSPRING HEALTH SERVICES INC | — | 2,514,077 | $107.12M | 0.98% |
| 27 | AMGEN INC | — | 303,722 | $106.86M | 0.98% |
| 28 | BOSTON SCIENTIFIC CORP | — | 1,603,771 | $100.64M | 0.92% |
| 29 | HCA HEALTHCARE INC | — | 206,215 | $97.59M | 0.90% |
| 30 | GUARDANT HEALTH INC | — | 1,055,988 | $97.54M | 0.90% |
| 31 | CVS HEALTH CORP | — | 1,310,339 | $94.11M | 0.86% |
| 32 | KYMERA THERAPEUTICS INC | — | 1,002,367 | $83.49M | 0.77% |
| 33 | THE CIGNA GROUP | — | 300,304 | $80.11M | 0.74% |
| 34 | CG ONCOLOGY INC | — | 1,108,573 | $75.03M | 0.69% |
| 35 | CARDINAL HEALTH INC | — | 348,232 | $73.58M | 0.68% |
| 36 | ELEVANCE HEALTH INC | — | 244,278 | $71.51M | 0.66% |
| 37 | KRYSTAL BIOTECH INC | — | 273,451 | $70.64M | 0.65% |
| 38 | SCHOLAR ROCK HOLDING CORP | — | 1,369,780 | $67.34M | 0.62% |
| 39 | IONIS PHARMACEUTICALS INC | — | 882,823 | $66.29M | 0.61% |
| 40 | BRIDGEBIO PHARMA INC | — | 864,149 | $64.17M | 0.59% |
| 41 | CHUGAI PHARMA CO | — | 1,141,000 | $62.92M | 0.58% |
| 42 | STRUCTURE THERAPEUTICS INC ADR | — | 1,273,207 | $61.37M | 0.56% |
| 43 | PRAXIS PRECISION MEDICINES INC | — | 189,301 | $60.99M | 0.56% |
| 44 | CELCUITY INC | — | 531,000 | $60.61M | 0.56% |
| 45 | ROYALTY PHARMA PLC | — | 1,241,743 | $59.57M | 0.55% |
| 46 | CENCORA INC | — | 179,717 | $56.46M | 0.52% |
| 47 | CENTESSA PHARMACEUTICALS LTD ADR | — | 1,367,577 | $54.32M | 0.50% |
| 48 | VERA THERAPEUTICS INC | — | 1,235,806 | $49.72M | 0.46% |
| 49 | NUVALENT INC-A | — | 459,791 | $47.11M | 0.43% |
| 50 | APOGEE THERAPEUTICS INC | — | 555,098 | $46.72M | 0.43% |
1 / 6
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.